Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

608 ARTÍCULOS , VIENDO DEL 586 AL 600

VMAT2 Inhibitors for Tardive Dyskinesia-Practice Implications

Peckham AM, Nicewonder JA.

J Pharm Pract. 2019 Aug;32(4):450-457. doi: 10.1177/0897190018756512. Epub 2018 Feb 18.

TSFM mutations cause a complex hyperkinetic movement disorder with strong relief by cannabinoids

Traschütz A, Hayer SN, Bender B, Schöls L, Biskup S, Synofzik M.

Parkinsonism Relat Disord. 2019 Mar;60:176-178. doi: 10.1016/j.parkreldis.2018.09.031. Epub 2018 Sep 29.

Movement disorders associated with neuronal antibodies

Dash D, Pandey S.

Acta Neurol Scand. 2019 Feb;139(2):106-117. doi: 10.1111/ane.13039. Epub 2018 Nov 6.

Restless Legs Syndrome in NKX2-1-related chorea: An expansion of the disease spectrum

Iodice A, Carecchio M, Zorzi G, Garavaglia B, Spagnoli C, Salerno GG, Frattini D, Mencacci NE, Invernizzi F, Veneziano L, Mantuano E, Angriman M, Fusco C.

Brain Dev. 2019 Mar;41(3):250-256. doi: 10.1016/j.braindev.2018.10.001. Epub 2018 Oct 21.

Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders

Plotkin JL, Goldberg JA.

Neuroscientist. 2019 Aug;25(4):359-379. doi: 10.1177/1073858418807887. Epub 2018 Oct 31.

Huntington disease: A quarter century of progress since the gene discovery

Testa CM, Jankovic J.

J Neurol Sci. 2019 Jan 15;396:52-68. doi: 10.1016/j.jns.2018.09.022. Epub 2018 Sep 27.

Treatment of psychiatric disturbances in common hyperkinetic movement disorders

Berardelli I, Pasquini M, Conte A, Bologna M, Berardelli A, Fabbrini G.

Expert Rev Neurother. 2019 Jan;19(1):55-65. doi: 10.1080/14737175.2019.1555475. Epub 2018 Dec 10.

Network Imaging in Parkinsonian and Other Movement Disorders: Network Dysfunction and Clinical Correlates

Niethammer M, Eidelberg D.

Int Rev Neurobiol. 2019;144:143-184. doi: 10.1016/bs.irn.2018.10.004. Epub 2018 Nov 28.

Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review

Schirinzi T, Garone G, Travaglini L, Vasco G, Galosi S, Rios L, Castiglioni C, Barassi C, Battaglia D, Gambardella ML, Cantonetti L, Graziola F, Marras CE, Castelli E, Bertini E, Capuano A, Leuzzi V.

Parkinsonism Relat Disord. 2019 Apr;61:19-25. doi: 10.1016/j.parkreldis.2018.11.019. Epub 2018 Nov 16.

Chorea-Acanthocytosis Presenting as Autosomal Recessive Epilepsy in a Family With a Novel VPS13A Mutation

Weber J, Frings L, Rijntjes M, Urbach H, Fischer J, Weiller C, Meyer PT, Klebe S.

Front Neurol. 2019 Jan 9;9:1168. doi: 10.3389/fneur.2018.01168. eCollection 2018.

Hemizygous UBA5 missense mutation unmasks recessive disorder in a patient with infantile-onset encephalopathy, acquired microcephaly, small cerebellum, movement disorder and severe neurodevelopmental delay

Low KJ, Baptista J, Babiker M, Caswell R, King C, Ellard S, Scurr I.

Eur J Med Genet. 2019 Feb;62(2):97-102. doi: 10.1016/j.ejmg.2018.06.009. Epub 2018 Jun 12.

Movement disorders in cerebrotendinous xanthomatosis

Stelten BML, van de Warrenburg BPC, Wevers RA, Verrips A.

Parkinsonism Relat Disord. 2019 Jan;58:12-16. doi: 10.1016/j.parkreldis.2018.07.006. Epub 2018 Jul 19.

The glucose transporter type 1 (Glut1) syndromes

Koch H, Weber YG.

Epilepsy Behav. 2019 Feb;91:90-93. doi: 10.1016/j.yebeh.2018.06.010. Epub 2018 Jul 31.

Identifying SYNE1 ataxia and extending the mutational spectrum in Korea

Kim JS, Kim AR, Youn J, Lee C, Kim NS, Park WY, Park JK, Kim NKD, Cho JW.

Parkinsonism Relat Disord. 2019 Jan;58:74-78. doi: 10.1016/j.parkreldis.2018.08.009. Epub 2018 Aug 13.

Widening the phenotypic spectrum - Non epileptic presentation of folate transporter deficiency

Tabassum S, AlAsmari A, AlSaman AA.

J Clin Neurosci. 2019 Jan;59:341-344. doi: 10.1016/j.jocn.2018.10.075. Epub 2018 Nov 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias